This 50-minute course covers precision medicine and its clinical applicability to veterinary oncology. We will explore innovation in cancer medicine, the definition of “precision medicine,” the role genomics plays in human oncology diagnosis and treatment planning, and the progression of genomic data and utility in veterinary oncology. The clinical relevance of genomic mutations in canine cancer will be discussed. Examples of the growing role of cancer genomic diagnostics in veterinary oncology will be analyzed through real-world examples.
Dr. David Haworth joined Vidium when it was still a dream, and with his help, it became a reality. David’s 20+ years in the animal health industry make him the expert guide and navigator of our team’s ship for the overall efforts of the animal health business.
Prior to joining Vidium, David was president of PetSmart Charities in the US and Canada, and before that he was the CEO of Morris Animal Foundation. He spent time as a Director of Global Alliances and a Director of Research and Development at Pfizer Animal Health (now Zoetis). He holds DVM and PhD degrees from Colorado State University and completed a postdoctoral fellowship at Colorado State University’s Flint Cancer Center.
David’s golden retriever, Bridger, was diagnosed with a stage 2 (high) mast cell tumor in 2019 and became the first client for SearchLight DNATM. With these findings, Bridger’s veterinary oncologist was able to choose a treatment course that has Bridger swimming, chasing birds, and barking at the mail carrier without even knowing he has cancer. Bridger enjoys long walks in the Arizona desert and sunset swims with his dad.
As Vidium’s chief scientific officer and founder, Dr. Will Hendricks stands at the helm of our humble ship and guides the team through the uncharted waters of veterinary precision medicine. Aspirational, thoughtful, and rooted in the core belief that science should be both transparent and unimpeachable, Will’s approach to serving the veterinary community guides overall research and development efforts.
Will maintains an Assistant Professorship in the Integrated Cancer Genomics Division at TGen, where his research led to the development of our inaugural assay. Before joining TGen in 2013, Will was a postdoctoral fellow and graduate student at Johns Hopkins School of Medicine where he trained with founders of the field of cancer precision medicine, including Drs. Vogelstein, Papadopoulos, and Kinzler. He has a PhD in Cellular and Molecular Medicine from The Johns Hopkins University School of Medicine, a BS from Arizona State University, and a BA from Grand Canyon University.
Will and his family rescued their dog, Jake, in 2017, and they’ve been inseparable ever since. Jake is one of many Hendricks pets that fuel Will’s drive to provide a better future for pets everywhere. But Jake doesn’t know that. All Jake knows is that zoomies after bathtime and burying hot dogs in the front yard are his favorite pastimes, and he couldn’t be a happier, more lovable dog.
This program has been approved for 1 hour of continuing education credit in jurisdictions that recognize RACE approval.